Determination of the genotype of a panel. of human tumor cell lines for the human homologues of yeast cell cycle checkpoint control genes: Identification of cell lines carrying homoallelic missense base substitutions
Y. Ejima et Lc. Yang, Determination of the genotype of a panel. of human tumor cell lines for the human homologues of yeast cell cycle checkpoint control genes: Identification of cell lines carrying homoallelic missense base substitutions, SOM CELL M, 25(1), 1999, pp. 41-48
A number of human homologues of yeast cell cycle checkpoint control genes h
ave been identified recently. In this study, the sequence alterations in si
x of such novel human genes (hRAD1, hRAD9, hRAD17, hHUS1, CHK1 and CHES1) w
ere analyzed by PCR-single-strand conformational polymorphism (PCR-SSCP) me
thod on a panel of 25 human tumor cell lines in an attempt to search for po
ssible in vivo cases where any of the checkpoint-related genes are altered
in human systems. For hRAD9, hHUS1 or CHK1, no SSCP variant was detected in
any of the cell lines tested indicating a high stability of these genes in
human cancer. Most of the SSCP variants found in the other three genes wer
e due to single nucleotide base substitutions. Two cell lines were found to
be homozygous for missense-type base substitutions, i.e., Saos-2 was homoa
llelic for 1637T --> G in hRAD 17; and COLO320DM for 1189G --> A in CHES1,
indicating a possible use of these cell lines for further study. The former
nucleotide change in hRAD17, which causes a change of amino acid from argi
nine to lysine at codon 546, was supposed to be polymorphic. Considering th
at lysine, but not arginine, is the amino acid that is well conserved among
fission yeast, mouse and monkey at the corresponding position, coexistence
of both alleles in human may have a functional or selectional implication.